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Abstract 21 
 22 
The feasibility of winemaking waste (WW) as source of active phenolic compounds 23 
against Campylobacter was evaluated using a mixture of ethanol-water (50% v/v) as 24 
extraction solvent. The winemaking waste extract (WWE) was active against all the 25 
strains tested, and most of them were inhibited at WWE concentrations between 40-100 26 
mg GAE/L. However, different lactic acid bacteria (LAB) strains were practically 27 
unaffected by WWE, suggesting a selective antibacterial effect of WWE against 28 
Campylobacter. The fractioning and phenolic characterization of WWE using HPLC-29 
MS showed that catechins and proanthocyanidins were the main compounds involved in 30 
the antibacterial effect. Among them, the structural verification using pure phenolic 31 
standards showed that epicatechin gallate and resveratrol were the most active 32 
compounds against Campylobacter. We conclude that the study of the main 33 
mechanisms involved in the antibacterial activity against Campylobacter of epicatechin 34 
gallate, resveratrol, and other related compounds presenting gallate side-chain, can 35 
contribute for future design of useful antibacterials against this pathogen. 36 
 37 
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Introduction 43 
Grapes used for the wine industry constitute around eighty percent of the 44 
worldwide grape production, being Spain the main producer (Fontana, Antoniolli & 45 
Bottini, 2013). The largest fraction of winery waste is the winemaking waste (WW), 46 
consisting of the skins, seeds, and stems left after juice or wine is pressed. Red wine, 47 
fermented on the skins and then pressed, is the main source of WW. It is a complex 48 
mixture of polysaccharides, fermentation by-products, dietary fiber, and polyphenols 49 
amongst others (Yu & Ahmedna, 2013). Grapes are particularly rich in bioactive 50 
polyphenols, especially flavonoids, stilbenes, and phenolic acids. However, even though 51 
some polyphenols are extracted into wine, the majority remains in the WW, due to the 52 
poor extraction during the winemaking process (Friedman, 2014).  In this regard, it is 53 
estimated that in Europe alone, 14.5 million tons of grape by-products are produced 54 
annually (Chouchouli, Kalogeropoulos, Konteles, Karvela, Makris & Karathanos, 55 
2013). The large amount of waste produced after winemaking, in addition to being a 56 
great loss of valuable materials, also raises serious management problems, both from 57 
the economic and environmental point of view (Mateo & Maicas, 2015). For this 58 
reason, winery by-products arising from industry generates the need to find alternative 59 
ways for their utilization. The main industrial applications for WW include its use as 60 
source of various products such as ethanol, alcoholic beverages, tartaric and citric acid, 61 
fertilizer and dietary fiber (Teixeira, Baenas, Dominguez-Perles, Barros, Rosa, Moreno 62 
& Garcia-Viguera, 2014). However, some properties of WW are incompatible with 63 
agricultural requirements and therefore WW must be conditioned before use. For 64 
example, the high level of polyphenols in WW generate some concerning when it is 65 
used as animal feed, due to its low digestibility (Baumgärtel, Kluth, Epperlein & 66 
Rodehutscord, 2007) or as fertilizer, causing inhibition in the germination of crops 67 
(Negro, Tommasi & Miceli, 2003). However, this disadvantage may be turned to an 68 
advantage when WW is used as a source of polyphenols enriched extracts, thus 69 
combining corporate profitability with a significant advance in environmental protection 70 
around the winemaking zones (Anastasiadi, Chorianopoulos, Nychas & Haroutounian, 71 
2009). There is extensive information available on the biological activities and potential 72 
health benefits of WW phenolic compounds (Teixeira et al., 2014; Friedman, 2014). 73 
Among their properties, the antibacterial character has gained interest in the last years 74 
due to their promising use as an alternative to traditional antibiotic and disinfectants 75 
(Friedman, 2014; Taylor, 2013). Between the foodborne bacterial pathogens affecting 76 
humans, campylobacters are the leading cause of bacterial diarrheal disease worldwide 77 
(Ganan, Silvan, Carrascosa & Martinez-Rodriguez, 2012). In the European Union, 78 
campylobacteriosis was the most commonly reported zoonosis, with 214,268 confirmed 79 
human cases in 2012 (EFSA Journal, 2014). 80 
In the last years, the rise in the incidence of infections caused by antibiotic-81 
resistant strains of Campylobacter makes this illness increasingly difficult to treat 82 
(Zhang & Plummer, 2008), and the same applies to the emergence of Campylobacter 83 
strains resistant to industrial disinfectants (Mavri, Kurinčič & Možina, 2012). 84 
Accordingly, the tendency for searching natural and sustainable strategies to reduce the 85 
incidence of Campylobacter is rising (Ganan et al., 2012). Some wine and grape 86 
phenolic compounds have previously proved to be effective against some 87 
Campylobacter strains (Silvan, Mingo, Hidalgo, de Pascual-Teresa, Carrascosa & 88 
Martinez-Rodriguez, 2013; Ganan, Martinez-Rodriguez & Carrascosa, 2009). For this 89 
reason, the main purpose of the present work was to evaluate the feasibility of WW as a 90 
source of active phenolic compounds against Campylobacter, also assessing its impact 91 
on probiotic lactic acid bacteria (LAB) and establishing a relation between phenolic 92 
structure and antibacterial function. 93 
 94 
2. Materials and methods 95 
2.1. Extract preparation 96 
The winemaking waste extract (WWE) was obtained from a WW of Tempranillo 97 
variety, following the procedure described by Pallauf, Rivas-Gonzalo, del Castillo, 98 
Cano & de Pascual-Teresa (2008) with some modifications. Briefly, WW was 99 
homogenized using an Ultra-Turrax T25 (IKA-Werke GmbH & Co., Staufen, Germany) 100 
for 5 min. to obtain 100 g of homogenate. 100 mL of ethanol-water (50% v/v) was 101 
added to the homogenate and mixed for 15 min. Afterwards, it was centrifuged for 10 102 
min. at 4500 x g and the supernatant was collected. The extraction process was repeated 103 
twice more. The extracts were combined, filtered through a Büchner funnell and 104 
concentrated at 30ºC using a rotary evaporator (BÜCHI Labortechnik GmbH, Essen, 105 
Germany). The extract obtained was made up to 100 mL of MilliQ® water. The 106 
aqueous extract was stored at -20ºC. 107 
2.2. Bacterial strains, growth media and culture conditions 108 
The microorganisms used in this study included 12 different strains of 109 
Campylobacter (8 of C. jejuni and 4 of C. coli ) and 10 strains of LAB (3 Lactobacillus 110 
casei, 2 L. plantarum, and 1 L. salivarius, L. paracasei, L. rhamnosus, Enterococcus 111 
faecium, and Pediococcus damnosus). Strain specification and origin of the specimen is 112 
provided in Table 1. 113 
All strains were stored at -80ºC. Liquid growth medium for Campylobacter 114 
strains consisted of Brucella Broth (BB) (Becton, Dickinson, & Company, New Jersey, 115 
USA). The agar plating medium consisted of Müeller-Hinton agar supplemented with 116 
5% defibrinated sheep blood (MHB) (Becton, Dickinson, & Company). The frozen 117 
strains were reactivated by inoculation in MHB and incubation under microaerophilic 118 
conditions (85% N2, 10% CO2, 5% O2) using a Variable Atmosphere Incubator (VAIN) 119 
(MACS-VA500) (Don Whitley Scientific, Shipley, UK) at 42ºC for 48 h. Isolated 120 
colonies were inoculated into 50 mL of BB and incubated under stirring at 130 rpm on 121 
an orbital shaker (Elmi Ltd., Riga, Latvia) at 42ºC for 24 h in microaerophilic 122 
conditions in the VAIN. These bacterial inocula cultures (~1 x 108 colony forming units 123 
(CFU/mL) were used for the antibacterial activity assays. 124 
For LAB, the liquid growth medium consisted of MRS broth (Laboratorios 125 
Conda, Madrid, Spain), supplemented with 10% agar for the plating medium. Cultures 126 
of LAB were prepared as follows: the frozen strain were reactivated by plating in MRS 127 
agar and incubated at 37ºC in a 5% CO2 humidified atmosphere (Inco 2, Memmert, 128 
Schwabach, Germany) for 48 h. Isolated colonies were then inoculated in MRS broth 129 
and incubated at 37ºC at 130 rpm in an Infors HT Multitron humidified shaker (Infors 130 
HT, Bottmingen, Switzerland) for 24 hours. These bacterial inocula cultures (~1 x 108 131 
CFU/mL) were used for the assays. 132 
2.3. Evaluation of the antibacterial activity of WWE 133 
The antibacterial activity of WWE against Campylobacter and LAB strains was 134 
determined as follows: 1 mL of WWE was transferred into different flasks containing 4 135 
mL of BB (for Campylobacter assays) or MRS (for LAB assays). Bacterial inocula (50 136 
µL with ~1 x 108 CFU/mL) were then inoculated into the flasks under aseptic 137 
conditions. All cultures were prepared in triplicate and incubated microaerobically at 138 
42ºC for 24 h (130 rpm) in the VAIN (for Campylobacter) or at 37ºC for 24 h (130 rpm) 139 
in the Infors incubator (for LAB). Positive growth controls were prepared using 0.9% 140 
saline solutions instead WWE. Minimal inhibitory concentration (MIC) was defined as 141 
the lowest amount of extract that provokes a significant quantitative decrease (p < 0.05) 142 
in the viability respect to the control growth after 24 h of treatment. Minimal 143 
bactericidal concentration (MBC) was defined as the lowest bactericidal concentration 144 
(detection limit 30 CFU per plate) of extract after 24 h of treatment. After incubation, 145 
serial decimal dilutions of mixtures were prepared in 0.9% saline solution and plated 146 
(20 µL) onto fresh MHB agar and incubated microaerobically at 42ºC in the VAIN. The 147 
CFU was assessed after 48 h of incubation. Results were expressed as log CFU/mL. 148 
2.4. Characterization of the phenolic composition of WWE 149 
The total phenolic content (TPC) in WWE was determined in accordance with 150 
the Folin-Ciocalteu micromethod as previously described by Silvan et al., (2013). 151 
Results were expressed as milligram of gallic acid equivalents per liter of extract (mg 152 
GAE/L). Individual phenolic compounds were determined by HPLC analyses and mass 153 
spectrometry detection (MS). All HPLC analyses were carried out on a Hewlett Packard 154 
Agilent 1200 Series liquid chromatography system equipped with a quaternary pump 155 
and a photodiode array detector (DAD) (Agilent Technologies, Waldrom, Germany). 156 
The column used was a Phenomenex Luna C18 column (4.6 x 150 mm, 5 mm) 157 
(Phenomenex, California, USA) which was set thermostatically at 25ºC. 158 
Chromatographic data were acquired and processed using an Agilent Chemstation for 159 
LC 3D system (Rev. B.04.01) (Agilent Technologies). The HPLC method conditions 160 
were as described by Silvan et al (2013). Briefly, the binary mobile phase used for 161 
analyses were aqueous 4.5% formic acid (A) and HPLC-grade acetonitrile (B) at a flow 162 
rate of 0.5 mL/min. The elution was starting with 10% B, the gradient was 20% B from 163 
0 to 20 min, 25% B from 20 to 30 min, and 35% B from 30 to 50 min. Detection 164 
wavelengths were 280, 320, 440 and 520 nm and samples were analyzed in triplicate. 165 
Peaks were identified by comparing their retention time and UV-vis spectra with the 166 
reference compounds, and the data were quantified using the corresponding curves of 167 
the reference compounds as standards. In order to confirm the identity of the recorded 168 
compounds, additional analyses were performed by using HPLC-MS. For MS analysis 169 
an Agilent 1100 series liquid chromatograph/mass-selective detector equipped with a 170 
quadrupole (G1946D) mass spectrometer (Agilent Technologies) was used, employing 171 
the same conditions described above for separation and elution. Electrospray ionization 172 
in the positive mode was used. The electrospray capillary voltage was set to 2500 V, 173 
with a nebulizing gas flow rate of 12 L/min and a drying gas temperature of 150ºC. 174 
2.5. Fractioning of WWE 175 
The main phenolic compounds present in the WWE were fractioned by semi-176 
preparative reverse-phase high-performance liquid chromatography (RP-HPLC) as 177 
previously reported Silvan et al. (2013).  The fractions (F1, F2, F3 and F4) were 178 
collected automatically with a fraction collector model II (Waters Corp., Milford, 179 
Massachusetts, USA). The chromatographic run was repeated 20 times to obtain 180 
adequate sample volume to be used for the further analyses. The collected fractions 181 
were rotary evaporated at 35ºC to reduce the volume. After that, the concentrates 182 
obtained for each fraction were completed to the total volume injected (5.5 mL) with 183 
distilled water. Samples were filter sterilized (0.22 µm, Sarstedt, Nümbrecht, Germany), 184 
and stored at -20ºC until use. The collected fractions were used to determine the 185 
antibacterial activity against C. jejuni 11168. Phenolic composition of collected 186 
fractions was determined following the HPLC analyses and MS detection described 187 
above. 188 
2.6. Verification of antibacterial response using pure standards 189 
The main phenolic compounds identified in F2 (active fraction) were tested 190 
against C. jejuni 11168 viability as pure compounds. The assayed compounds (quercetin 191 
3-glucoside, syringic acid, gallic acid, catechin, epicatechin, epicatechin-gallate, 192 
delphinidin-3-glucoside, t-resveratrol and t-piceid) were purchased from Extrasynthese 193 
(Lyon, France). Antibacterial resistance was determined using the broth microdilution 194 
method. This was carried out in BB and prepared in triplicate with an inocula of ~1 x 195 
106 CFU/mL using 96 well-microtitre plates (Sarstedt). Serial dilutions of each phenolic 196 
standard (5 to 1000 mg/L) were prepared. The wells without the addition of the phenolic 197 
standards were used as experimental controls. After 48 h of incubation in the VAIN at 198 
42ºC, the CFU was assessed as described above. Antibacterial activity was carried out 199 
in triplicate. 200 
2.7. Statistical analysis 201 
The results were reported as means ± standard deviation (SD). The data was 202 
analyzed by analysis of variance (ANOVA) with a post hoc Duncan test (p<0.05). All 203 
statistical tests were performed with IBM SPSS Statistics for Windows, Version 19.0 204 
(IBM Corp., Armonk, NY, USA). 205 
3. Results and discussion 206 
3.1. Antibacterial activity of the WWE against Campylobacter 207 
The results of the antibacterial activity of WWE against Campylobacter strains 208 
are presented in Table 2. In a similar way as observed in previous works carried out 209 
using grape extracts or grape seed extracts (Silvan et al., 2013; Mingo, Carrascosa, de 210 
Pascual-Teresa & Martinez-Rodriguez, 2014), WWE was active against all the strains 211 
studied. The grade of efficiency of the extract was related with the strain analyzed, 212 
being the MIC between 40-160 mg GAE/L and the MBC between 100-320 mg GAE/L. 213 
Most of the studied strains were inhibited at WWE concentrations between 40-100 mg 214 
GAE/L. These results demonstrate the efficacy of WWE as inhibitor of Campylobacter 215 
growth, in spite of the modifications in the phenolic fraction during winemaking 216 
(Friedman, 2014). 217 
In practical terms, the antibacterial activity of a phenolic extract is very 218 
interesting in the case that it is observed at concentrations below 100 mg/L (Rios & 219 
Recio, 2005), because is not apparently very difficult to get this concentration in most 220 
of the extraction procedures to prepare natural extracts. In this work, the solvent used 221 
for the extract preparation was a mixture of ethanol-water (50% v/v). Several 222 
researchers have described that the presence of water in the extraction solvent used for  223 
grape by-products extraction increases the permeability of cell tissues, improving the 224 
recovery of water soluble compounds (Fontana et al, 2013). Although higher yields 225 
have been obtained using methanol as unique solvent (Fontana et al., 2013; Mingo et 226 
al., 2014) these results indicate that the use of an economic and environmentally-227 
friendly solvent as ethanol can be enough to obtain an active WWE against 228 
Campylobacter. This is consequent with the fact that Campylobacter have proved to be 229 
more sensitive than others microorganisms to several phenolic compounds (Friedman, 230 
2014). 231 
3.2. Effect of WWE on probiotic lactic acid bacteria (LAB) 232 
Different LAB species are integrated as part of human gut microbiota, positively 233 
contributing to the health and wellbeing. In the present work, we have evaluated the 234 
WWE effect on 10 potentially probiotic LAB strains. In Table 3 it is shown that the 235 
inhibitory effect of WWE on LAB strains was significantly lower than the observed for 236 
Campylobacter strains. The highest concentration of the WWE used for Campylobacter 237 
studies  (320 mg GAE/L, bactericidal for all the Campylobacter strains), only inhibited 238 
1.5 log of LAB growth respect to experimental controls, while two strains (L. casei Ha 239 
and L. casei CIAL2) were not affected by WWE. This behavior suggests that WWE 240 
could have a selective effect on Campylobacter growth. Previously, other researchers 241 
have observed that LAB can be more resistant than other bacteria to phenolic 242 
compounds. For example, Lee, Jenner, Lowa & Lee (2006) found that strains of 243 
probiotic LAB and bifidobacteria were less affected by tea polyphenols than other 244 
bacterial groups. In the same way, Hervet–Hernandez , Pintado, Rotger & Goñi. (2009) 245 
observed that the polyphenols present in an extract of grape pomace did not inhibit the 246 
growth of L. acidophilus CECT 903, having a stimulatory effect on the growth of this 247 
strain. In the present work, we have observed a similar behavior for L. salivarius IFa 248 
strain. For this strain, the growth increased proportionally with increasing concentration 249 
of WWE (Table 3). Although there are significant differences between the LAB strains, 250 
the global behavior indicates that LAB growth was relatively unaffected by WWE. 251 
3.3. Phenolic characterization of WWE 252 
In Table 4 it is shown the composition in individual phenolic compounds of the 253 
WWE. Flavanols (catechins and proanthocyanidins) were the major components, 254 
accounting for around the 75.4% of the phenolic compounds in the extract. They were 255 
followed by flavonols (32.4%). Anthocyanins, phenolic acids and stilbenes were in 256 
minor proportion. Despite the effects of the fermentation and the mildest process used 257 
for phenolic extraction, the distributions in families of individual phenolic compounds 258 
were similar to those obtained from the GSE (Silvan et al., 2013) or grapes (Mingo et 259 
al., 2014). Also, in the WWE, t-resveratrol and t-piceid were found and quantified. The 260 
recovery of these compounds may be improved when using by-products of fermentation 261 
due to the influence of variables such as yeast strain, maceration time, use of enzymes, 262 
aging, etc., during winemaking (Feijoo, Moreno & Falque, 2008). Within the catechins 263 
and proanthocyanidins, the most abundant compound was epicatechin (156.7 mg/L), 264 
followed by proanthocyanidin B2 (110.2 mg/L). Among the flavonols, the most 265 
abundant were quercetin-3-glucoside (94.4 mg/L) and quercetin-3-rhamnoside (89.4 266 
mg/L). Malvidin-3-glucoside was the major anthocyanin, while the phenolic acids gallic 267 
and syringic acid were identified and quantified in similar proportions. These phenolic 268 
compounds have also been identified in others WWE (Jara-Palacios, Hernanz, 269 
Cifuentes-Gomez, Escudero-Gilete, Heredia & Spencer, 2015; Melo, Massarioli, 270 
Denny, dos Santos, Franchin, Pereira, Vieira, Rosalen & de Alencar, 2015; Yu & 271 
Ahmedna, 2013). The concentration of these compounds tends to vary, among others, 272 
due to variables such as grape variety and extraction process. Further, WWE was 273 
fractioned by RP-HPLC obtaining four fractions. The phenolic composition of these 274 
fractions is showed in Table 5. Fraction 1 (F1) included only gallic acid and 275 
proanthocyanidin B1, while fraction 2 (F2) was mainly formed by catechins and 276 
proanthocyanidins. In fraction 3 (F3) eluted the flavonols, anthocyanins, and t-277 
resveratrol, while no phenolic compounds were found in fraction 4 (F4). The analysis of 278 
the antibacterial activity of each fraction against the most resistant strain tested (C. 279 
jejuni 11168) showed that the inhibitory effect observed in the whole WWE is 280 
concentrated in the compounds eluting in F2 (Figure 1). This result links the catechins 281 
and proanthocyanidins with the antibacterial effect of WWE. In addition to being the 282 
major phenolic compounds constituting the extract, there are several reports describing 283 
the antibacterial effect of catechins and proanthocyanidins against different bacteria 284 
(Nakayama, Shimatani, Ozawa, Shigemune, Tsugukuni, Tomiyama, et al., 2013; 285 
Reygaert, 2014). Moreover, we have previously observed some antibacterial effect of 286 
pure epicatechin on C. jejuni (Ganan et al., 2009; Mingo et al., 2014). The fractioning of 287 
a commercial grape seed extract active against Campylobacter also suggested that some 288 
catechins were involved in the antibacterial effect of the whole extract (Silvan et al, 289 
2013), however it was difficult to associate the effect to a specific compound or family 290 
of compounds, because three of the four obtained fractions had antibacterial activity 291 
against Campylobacter. Now, having only an active fraction (F2), we checked the 292 
individual response of each identified compound against C. jejuni using pure phenolic 293 
standards. 294 
3.4. Verification of antibacterial effect using pure phenolic standards 295 
The antibacterial activity of the selected phenolic standard against C. jejuni is 296 
shown in Table 6. All the pure phenolic compounds assayed were identified in the 297 
WWE and in the active fraction F2. The results showed that epicatechin gallate (ECG) 298 
was the most active compound, with a MIC of 10 mg/L and a MBC of 20 mg/L. In both 299 
cases, these values are lower than the concentration of this compound in WWE (25.9 300 
mg/L; Table 4), suggesting its outstanding role in the antibacterial activity. ECG is one 301 
of the main catechins in grapes and green tea, and it has shown antibacterial activity 302 
against both gram-negative and gram positive bacteria, also acting synergistically with 303 
other phenolic compounds and antibiotics (Reygaert, 2014). This fact could be relevant 304 
taking in account that this compound is part of an extract enriched in phenolic 305 
compounds. The gallate side chain of this compound has been associated with its 306 
antibacterial activity (Friedman, Henika, Levin, Mandrell & Kozukue, 2006) and the 307 
main mechanisms of action described results from the compound binding to the 308 
bacterial lipid bilayer cell membrane, causing damage or  dysfunction of the membrane 309 
(Reygaert, 2014; Cushnie & Lamb, 2011). Specifically in Campylobacter, the close 310 
related compound epigallocatechin gallate (EGCG) modifies Campylobacter multidrug 311 
efflux systems, restoring macrolide efficacy in resistant strains (Kurinčič, Klančnik & 312 
Možina., 2012). Also as part of a grape seed extract, epicatechin gallate was in the most 313 
active fraction of phenolic compounds against Campylobacter (Silvan et al, 2013). 314 
Epicatechin, with a very low activity (MIC 1000 mg/L) and catechin (without 315 
antibacterial activity) were the other catechins analyzed. No pure standard was available 316 
for the dimer EC-ECG, but its similar structure, carrying a gallate side chain, suggest 317 
that it can be also involved in the observed behavior. 318 
Another compound with a high antibacterial activity against C. jejuni was t-319 
resveratrol, with a MIC of 20 mg/L and MBC of 50 mg/L. However, its concentration in 320 
the extract was much lower (7.2 mg/L), which is consistent with the fact that the 321 
fraction with higher content in t-resveratrol (F3) did not show antibacterial activity 322 
against Campylobacter. Nevertheless, the high concentration of glycosylated resveratrol 323 
(t-piceid) in the extract indicates that it can be a potential source of active resveratrol 324 
against Campylobacter. 325 
The flavonol quercetin-3-glucuronide and the anthocyanin delphinidin-3-326 
glucoside were no active against C. jejuni. Gallic and syringic acid had a similar 327 
behavior, with a MIC of 600 and 400 mg/L, respectively. These values are higher than 328 
the concentrations of these compounds in the extract (between 20 and 26 mg/L) 329 
showing that apparently they are not involved directly in the antibacterial effect of 330 
WWE. 331 
 332 
4. Conclusions 333 
The results obtained in this work evidences that WW can be a good source to 334 
obtain active phenolic extracts against Campylobacter. Phenolic compounds remaining 335 
in fermentation by-products are active against Campylobacter and can be extracted 336 
using mild procedures, probably due to the effect of enzymatic activity and other 337 
previous winemaking procedures. Phenolic extracts active against Campylobacter have 338 
a smooth effect on probiotic LAB, suggesting a selective character of the inhibitory 339 
effect. Structure-function relationships were stablished for WWE, indicating that 340 
epicatechin gallate was the most active phenolic compound against Campylobacter. 341 
Moreover, WWE was rich in t-piceid, a potential source of resveratrol, also with high 342 
antibacterial activity against Campylobacter. Future work should be directed to know 343 
the mechanisms involved in the antibacterial activity against Campylobacter of 344 
epicatechin gallate, resveratrol, and other related compounds presenting gallate side-345 
chain, contributing in this way to design useful antibacterial against this pathogen. 346 
Antibacterials based in phenolic compounds are potentially applicable in the entire 347 
target sites of food chain were campylobacters remains, and could be a cheaper and 348 
feasible tool to fight against this pathogen. 349 
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Figure 1. Antibacterial activity of the WWE collected fractions against C. jejuni 11168. Results are 
the mean ± standard deviation of three determinations. Bars marked with the same letter indicate 
absence of significant differences by Duncan test (p < 0.05). 
 
 
 
Table 1. Source of Campylobacter and Lactic Acid Bacteria (LAB) strains obtained from clinical, 
veterinary, chicken food chain and collection libraries. 
Bacteria Strain Origin Source 
C. jejuni 
118 Clinical Hospital Carlos III, Madrid 
CIII Clinical Hospital Carlos III, Madrid 
LP1 Clinical Hospital La Paz, Madrid 
CN1 Veterinary CIALa 
11168 Collection NCTCb 
11351 Collection NCTC 
CIAL1 Chicken food chain CIAL 
CIAL2 Chicken food chain CIAL 
C. coli 
LP2 Clinical Hospital La Paz, Madrid 
CIAL3 Chicken food chain CIAL 
CIAL4 Chicken food chain CIAL 
CIAL5 Clinical CIAL 
L. casei  
Ha Food CIAL 
CIAL1 Food CIAL 
CIAL2 Food CIAL 
L. plantarum 748 Reference CECT
c 
749 Reference CECT 
L. salivarius IFa Food CIAL 
L. paracasei LC01(Hansen) Food CIAL 
L. rhamnosus 53103 Reference ATCCd 
E. faecium BIFI58 Food CIAL 
P. damnosus 20331 Reference DSMZe 
 
a Collection from Institute of Food Science Research (CIAL). 
b Bacterial cultures obtained from the National Collection of Types Cultures (NCTC), UK.  
c Bacterial cultures obtained from the Colección Española de Cultivos Tipo (CECT), Spain.  
d Bacterial cultures obtained from the American Type Culture Collection (ATCC), USA. 
e Bacterial cultures obtained from the German Collection of Microorganisms and Cell Cultures 
(DSMZ), Germany. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Antibacterial activity of WWE against Campylobacter strains. 
 
Results are the mean ± standard deviation of three determinations. Values in the same row 
marked with the same superscript letter indicate absence of significant differences (p < 0.05). 
* Calculated log of detection limit (30 CFU per plate). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                    WWE concentration (mg GAE/L) 
Strains 0 40 100 160 240 320 
C. jejuni LP1 8.3a ± 0.1 8.3a ± 0.0 2.2b ± 0.1 >1.5*c  >1.5*c  >1.5*c 
C. jejuni CIII 8.1a ± 0.1 8.1a ± 0.2 6.2b ± 0.1 >1.5*c  >1.5*c  >1.5*c 
C. jejuni CN1 8.4a ± 0.1 8.8a ± 0.0 4.5b ± 0.3 >1.5*c >1.5*c  >1.5*c 
C. jejuni 118 8.6a ± 0.1 5.0b ± 0.2 >1.5*c >1.5*c  >1.5*c  >1.5c 
C. jejuni 11168 8.6a ± 0.3 8.8a ± 0.2 8.7a ± 0.1 6.0b ± 0.1 4.3c ± 0.3 >1.5*d  
C. jejuni 11351 8.1a ± 0.1 8.4a ± 0.5 7.1b ± 0.1 3.5c ± 0.3 >1.5*d  >1.5*d  
C. jejuni CIAL1 8.3a ± 0.1 7.7b ± 0.3 6.9c ± 0.1 2.2d ± 0.3 >1.5*e  >1.5*e 
C. jejuni CIAL2 9.0a ± 0.2 8.8a ± 0.2 7.1b ± 0.2 4.1c ± 0.1 1.8d ± 0.2 >1.5*e  
C. coli  LP2 8.5a ± 0.1 8.4a ± 0.1 6.1b ± 0.2 3.1c ± 0.1 >1.5*d  >1.5*d  
C. coli CIAL3 9.0a ± 0.1 8.6b ± 0.2 7.2c ± 0.2 6.1d ± 0.2 2.2e ± 0.2 >1.5*f 
C. coli CIAL4 8.1a ± 0.2 8.1a ± 0.2 7.1b ± 0.2 5.0c ± 0.2 2.9d ± 0.2 >1.5*e  
C. coli CIAL5 9.0a ± 0.1 8.9a ± 0.1 7.9b ± 0.2 5.2c ± 0.3 2.7d ± 0.1 >1.5*e  
 
Table 3. Antibacterial activity of WWE against lactic acid bacteria strains (LAB). 
 
Results are the mean ± standard deviation of three determinations. Values in the same row 
marked with the same superscript letter indicate absence of significant differences by Duncan test 
(p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                     Concentration WWE (mg GAE/L) 
Strains 0 40 100 160 240 320 
E. faecium BIFI58 8.2a ± 0.1 8.2a ± 0.3 8.3a ± 0.1 8.2a ± 0.1 8.3a ± 0.1 7.9b ± 0.1 
L. casei CIAL1 8.2a ± 0.2 8.3a ± 0.2 8.4a ± 0.2 8.4a ± 0.3 8.0b ± 0.2 8.0b ± 0.1 
L. casei CIAL2 7.7a ± 0.2 7.8a ± 0.2 7.7a ± 0.2 7.8a ± 0.2 7.6a ± 0.3 7.5a ± 0.2 
L. casei Ha 7.4a ± 0.1 7.4a ± 0.4 7.6a ± 0.2 7.7a ± 0.3 7.5a ± 0.1 7.4a ± 0.2 
L. paracasei LC01 7.5a ± 0.1 7.5a ± 0.1 7.3a ± 0.2 7.4a ± 0.1 6.5b ± 0.2 6.0c ± 0.1 
L. plantarum 748  8.8a ± 0.1 8.7a ± 0.2 8.7a ± 0.3 8.4b ± 0.2 8.3b ± 0.2 8.0c ± 0.1 
L. plantarum 749 9.2a ± 0.1 9.1a ± 0.2 9.3a ± 0.2 9.1a ± 0.2 9.2a ± 0.1 8.5b ± 0.2 
L. rhamnosus 53103 9.0a ± 0.1 9.2a ± 0.1 8.9a ± 0.1 8.9a ± 0.2 8.6b ± 0.2 8.4b ± 0.2 
L. salivarius IFa 8.2b ± 0.1 8.3b ± 0.1 8.4b ± 0.2 8.6a ± 0.1 8.6a ± 0.1 8.7a ± 0.1 
P. damnosus 20331 8.2a ± 0.2 8.0b ± 0.3 7.8b ± 0.2 7.3c ± 0.2 7.1c ± 0.2 7.1c ± 0.3 
 
 
Table 4. Individual phenolic composition of WWE (mg/L of extract). 
Phenolic compound mg/L 
Flavonols  
Myricetin-3-glucoside  47.6 ± 0.4 
Quercetin-3-rutinoside  24.0 ± 0.3 
Quercetin-3-glucoside  94.4 ± 0.7 
Quercetin-3-rhamnoside  89.4 ± 0.5 
Quercetin-3-glucuronide 70.3 ± 0.6 
Kaempferol-3-rutinoside 10.1 ± 0.1 
Kaempferol-3-glucoside 28.0 ± 0.5 
Quercetin 37.9 ± 1.1 
Kampferol 15.2 ± 2.1 
  
Phenolic acids  
Syringic acid 20.4 ± 0.4 
Gallic acid 26.0 ± 1.3 
  
Flavanols  
Catechin (CAT)   88.0 ± 6.6 
Epicatechin (EC)   156.7 ± 12.2 
B1 (EC-CAT)   83.3 ± 4.3 
B2 (EC-EC) 110.2 ± 9.0 
Procyanidin trimer      96.1 ± 10.4 
Epicatechin gallate (ECG)  25.9 ± 1.5 
Procyanidin dimmer gallate  18.1 ± 0.2 
  
Anthocyanins  
Delphinidin-3-glucoside    23.1 ± 0.3 
Peonidin-3-glucoside    71.3 ± 0.6 
Malvidin-3-glucoside  125.7 ± 0.8 
Malvidin-3-glucoside-acetate     1.8 ± 0.1 
  
Stilbenes  
t-Resveratrol   7.2 ± 0.0 
t-Piceid 27.9 ± 0.7 
  
TPCa 2060.2 ± 104.3 
Results are the mean ± standard deviation of three determinations. 
a Total phenolic content is expressed as milligram of gallic acid 
equivalents per liter (mg GAE/L extract). 
 
 
 
 
 
 
 
Table 5. Phenolic composition of the WEE collected fractions (mg/L of extract) obtained 
by RP-HPLC. 
Compound F1 F2 F3 F4 
Flavonols 
Myricetin-3-glucoside     6.2 ± 0.1  
Quercetin-3-rutinoside n.d. n.d. 18.4 ± 0.0 n.d. 
Quercetin-3-glucoside n.d. n.d. 63.4 ± 0.2 n.d. 
Quercetin-3-rhamnoside n.d. n.d.   7.0 ± 0.0 n.d. 
Quercetin-3-glucuronide n.d. 21.6 ± 0.0 38.1 ± 0.1 n.d. 
Kaempferol-3-rutinoside n.d. n.d.   5.4 ± 0.1 n.d. 
Kaempferol-3-glucoside n.d. n.d. 16.0 ± 0.2 n.d. 
Quercetin n.d. n.d. 15.1 ± 0.1 n.d. 
Kampferol n.d. n.d.   5.3 ± 0.2 n.d. 
     
Phenolic acids 
Syringic acid n.d. 12.7 ± 0.5 n.d. n.d. 
Gallic acid 23.9 ± 1.6   0.7 ± 0.0 n.d. n.d. 
     
Flavanols 
Catechin  (CAT) n.d.   9.8 ± 0.5 n.d. n.d. 
Epicatechin (EC) n.d. 23.5 ± 0.8 n.d. n.d. 
B1 (EC-CAT) 34.2 ± 3.9 17.5 ± 0.5 n.d. n.d. 
B2 (EC-EC) n.d. 41.1 ± 0.2 n.d. n.d. 
Procyanidin trimer   n.d. 16.2 ± 0.5 n.d. n.d. 
Epicatechin gallate (ECG) n.d. 11.2 ± 0.4 n.d. n.d. 
Procyanidin dimmer gallate n.d. 13.6 ± 0.1 n.d. n.d. 
     
Anthocyanins 
Delfinidin-3-glucoside n.d. 12.7 ± 0.6 n.d. n.d. 
Peonidin-3-glucoside n.d.   0.7 ± 0.0 36.9 ± 0.5 n.d. 
Malvidin-3-glucoside n.d.   1.1 ± 0.1 85.6 ± 0.3 n.d. 
Malvidin-3-glucoside-acetate n.d. n.d.   0.3 ± 0.0 n.d. 
     
Stilbenes 
t-Resveratrol n.d. 1.0 ± 0.0  3.9  ± 0.0 n.d. 
t-Piceid n.d. 1.8 ± 0.0 17.3 ± 0.2 n.d. 
Results are the mean ± standard deviation of three determinations. 
n.d. = non detected. 
 
 
 
 
 
Table 6. Antibacterial activity of pure standards of phenolic compounds identified in WWE collected fraction F2. Fraction was obtained from WWE by RP-HPLC. 
 
Concentration 
(mg/L) Pure standards of phenolic compounds identified in fraction F2 
 Q3G SA GA CAT EC ECG D3G RV 
0 8.8a ± 0.2 9.8a ± 0.6 9.4a ± 0.8 9.2a ± 0.4 9.5a ± 0.4 8.9a ± 0.3 8.6a ± 0.2 9.2a ± 0.4 
5 8.6a ± 0.4 9.6a ± 0.4 9.2a ± 0.4 9.4a ± 0.3 9.7a ± 0.2 8.8a ± 0.5 8.4a ± 0.4 8.9a ± 0.3 
10 8.7a ± 0.2 9.5a ± 0.3 9.4a ± 0.6 9.2a ± 0.5 9.3a ± 0.5 3.6b ± 0.2 8.6a ± 0.3 9.1a ± 0.5 
20 8.7a ± 0.4 9.8a ± 0.3 9.2a ± 0.6 9.6a ± 0.4 9.5a ± 0.3 > 1.5*c 8.3a ± 0.6 6.3b ± 0.2 
50 8.5a ± 0.4 9.4a ± 0.6 9.5a ± 0.4 9.4a ± 0.3 9.4a ± 0.2 > 1.5*c 8.4a ± 0.2 > 1.5*c 
80 8.8a ± 0.3 9.3a ± 0.6 9.4a ± 0.6 9.2a ± 0.2 9.6a ± 0.3 > 1.5*c 8.5a ± 0.4 > 1.5*c 
100 8.7a ± 0.4 9.7a ± 0.4 9.3a ± 0.3 9.5a ± 0.2 9.6a ± 0.5 > 1.5*c 8.6a ± 0.3 > 1.5*c 
200 8.8a ± 0.3 9.7a ± 0.6 9.5a ± 0.4 9.3a ± 0.4 9.5a ± 0.3 > 1.5*c 8.6a ± 0.2 > 1.5*c 
400 8.8a ± 0.3 7.1b ± 0.6 9.3a ± 0.2 9.3a ± 0.3 9.6a ± 0.2 > 1.5*c 8.4a ± 0.2 > 1.5*c 
600 8.6a ± 0.4 6.4c ± 0.7 6.2b ± 0.2 9.2a ± 0.5 9.5a ± 0.4 > 1.5*c 8.3a ± 0.5 > 1.5*c 
800 8.4a ± 0.4 4.1d ± 0.2 5.0c ± 0.6 9.5a ± 0.5 9.6a ± 0.2 > 1.5*c 8.4a ± 0.3 > 1.5*c 
1000 8.7a ± 0.4 3.0e ± 0.4 4.8c ± 0.7 9.3a ± 0.6 8.2b ± 0.3 > 1.5*c 8.4a ± 0.2 > 1.5*c 
Results are the mean ± standard deviation of three determinations. Values in the same column marked with the same superscript letter indicate absence of significant 
differences by Duncan test (p < 0.05). Q3G (Quercetin-3-glucoside), SA (Syringic acid), GA (Gallic acid), CAT (Catechin), EC (Epicatechin), ECG (Epicatechin 
gallate), D3G (Delphinidin-3-glucoside), RV (Resveratrol). 
* Calculated log of detection limit (30 CFU per plate). 
